UNSPSC 51384613: Lonazolac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13097143QI, chemically known as 1h-pyrazole-4-acetic acid, 3-(4-chlorophenyl)-1-phenyl- but generally known as lonazolac, which bears US NIH Compound Identifier 68706. European Medicines Agency schedules Lonazolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08570MIG.

UNSPSC 51384613 Lonazolac is a Commodity code, but the recent state and local activity tagged under it does not match the code's nominal pharmaceutical scope. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) soliciting naloxone and safe drug deactivation systems—products unrelated to lonazolac, an anti-inflammatory medication. The mismatch suggests either a tagging error in the source data or a jurisdictional procurement taxonomy misalignment. Based on the available recent-opportunities record, this code shows little relevant activity aligned with its stated pharmaceutical definition.

The single visible opportunity reflects a county health department procurement for opioid-overdose response supplies rather than lonazolac inventory or dispensing. No evidence of state-level, municipal, school district, transit authority, or other issuing-body participation under this code appears in the recent record. Geographic activity is limited to Florida on the available posting. Without additional opportunities tagged correctly to the lonazolac code, the current signal does not support a pursue decision for vendors offering lonazolac products or related pharmaceutical services to state and local buyers.